Regenerative Skin Booster · Polynucleotide

Rejuran in Seoul — Sessions, Downtime & Pricing

Polynucleotide Skin Repair & Barrier Recovery

Rejuran polynucleotide regenerative skin-booster injection at Delight Dermatology, Seoul
Duration
20-30 min (full face); 10-15 min (periorbital or lip)
Sessions
3 induction (2-4 wk apart); maintenance 1 / 3-6 months
Downtime
24-48 hours visible papules
Smoother, healthier skin texture after a Rejuran course
Skin texture irregularityFine lines & dullnessMild atrophic acne scarringPeriorbital fine wrinkles
01Overview

Rejuran Treatment in Seoul

Rejuran polynucleotide skin booster at Delight Dermatology in Gangnam — a regenerative injectable for skin texture, fine lines, and post-procedure recovery, with board-certified dermatologist consultation.

Duration
20–30 min full face / 10–15 min periorbital or lip
Sessions
3 induction (2–4 wk); maintenance 1 / 3–6 months
Downtime
24–48 hours visible papules
Peak Result
Week 8–12 after full induction
02Timeline

Results Over Time

Rejuran is a regenerative skin booster for texture, fine lines, and barrier quality. The active ingredient is highly-purified polynucleotide (PN) from salmon DNA, made by Korea's PharmaResearch.

Ultherapy Prime — illustrative result at During injection01

During injection

Micro-injections are placed across the area. Topical anesthesia is usually applied to reduce discomfort.

Ultherapy Prime — illustrative result at Day 002

Day 0

Visible papules at injection sites. Mild swelling and redness.

Ultherapy Prime — illustrative result at Day 1–203

Day 1–2

Papules flatten. Makeup is typically resumed on Day 2.

Ultherapy Prime — illustrative result at Week 4 (sessions 1–2)04

Week 4 (sessions 1–2)

Texture and barrier improvement becomes visible.

Ultherapy Prime — illustrative result at Week 8–12 (full course)05

Week 8–12 (full course)

Peak effect. Maintenance every 3–6 months is commonly recommended.

Images are AI-generated for illustrative purposes only.

03Injectables & Solutions

Rejuran Polynucleotide

Rejuran (PharmaResearch) is a polynucleotide (PN) regenerative skin booster — an MFDS-approved Class IV device in Korea — that repairs skin quality rather than adding volume.

Rejuran (PharmaResearch) polynucleotide skin booster range
  • Polynucleotide (PN)

    Highly-purified PN from salmon DNA stimulates regeneration — improving texture, elasticity, and barrier, without adding volume.

  • Variant Range

    Healer (texture), HB / HB Plus (hydration + lidocaine), Eye (under-eye), and S (scar) — matched to your concern.

  • Gentle Regeneration

    Minimal pain and downtime versus laser; a regenerative rather than space-filling approach.

04Process

Treatment Process

Clinical Evaluation — Ultherapy Prime at Delight Dermatology01

Clinical Evaluation

The dermatologist evaluates the concern, depth of wrinkle/scar, and history — including known fish or salmon allergy.

Variant Selection — Ultherapy Prime at Delight Dermatology02

Variant Selection

A Rejuran variant is selected — Healer (texture), HB (hydration hybrid), HB Plus (lidocaine, periorbital), Eye (under-eye), or S (scar).

Injection Planning — Ultherapy Prime at Delight Dermatology03

Injection Planning

Topical anesthesia is applied; an intradermal microbolus plan is mapped (≤0.05 mL per point at 0.5–1 cm spacing).

Procedure — Ultherapy Prime at Delight Dermatology04

Procedure

A session typically takes 20–30 minutes full face; periorbital or lip sessions are shorter. Induction = 3 sessions at 2–4 week intervals.

05Before / After

Treatment Results

BeforeUltherapy Prime — before
AfterUltherapy Prime — after

Clinical photographs. Individual results vary with skin condition, age, and treatment plan.

06Aftercare

Recovery & Care

01

First 24–48h

No touching, hot showers, saunas, or exercise. Papules are normal — do not pick.

02

Day 3–7

Resume normal skincare. Avoid retinoids until skin settles. SPF 50+.

03

Week 2–4

Strict sun protection. Schedule the next session.

04

Long-term

Daily SPF 50+. Discuss combination protocols with your dermatologist.

Private treatment suite at Delight Dermatology
07FAQ

Frequently Asked Questions

Q.Is Rejuran FDA-approved?

Not as an injectable in the United States. Rejuran is MFDS-approved as a Class IV medical device in Korea (original Healer 2014, HB Plus 2021) and CE-marked in the EU. Topical PDRN-branded cosmetics may be sold under FDA cosmetic regulation in the US but are separate products from the injectable medical device. Honest regulatory framing is part of board-certified Anti-Aging specialist standards.

Q.How is Rejuran different from JUVELOOK, Sculptra, or HA fillers?

All four work on different layers and pathways. Rejuran (polynucleotide / PN) is a regenerative biostimulator — adenosine A2A receptor signaling + nucleotide salvage — that improves skin quality without adding volume. JUVELOOK (PDLLA + HA hybrid) and Sculptra (PLLA) stimulate fibroblast-driven collagen over months for structural support. HA fillers add immediate volume via space-occupying gel. Korean clinical practice routinely combines them at different sessions or depths for layered effect; selection depends on whether the concern is texture (Rejuran), structure (PDLLA/PLLA), or volume (HA).

Q.How many sessions and how soon will I see results?

Standard induction is 3 sessions at 2-4 week intervals. Skin texture changes typically become visible between session 2 and 3, with continued improvement 4-8 weeks after the last session. Maintenance is commonly cited at every 3-6 months but is not standardized in published trials.

Q.Does Rejuran completely remove acne scars?

No. The strongest available Rejuran-specific acne-scar evidence — Araco 2021 RCT — demonstrated significant improvement on Antera 3D imaging at 1 and 3 months versus placebo, but the trial was small and explicitly preliminary. Rejuran is best understood as an adjunct to fractional CO2 laser, subcision, or TCA CROSS — not as monotherapy for moderate-to-severe scarring.

Q.Is the procedure painful?

Yes — intradermal microbolus injection is genuinely uncomfortable. Topical anesthetic is standard. The HB Plus formulation includes lidocaine to reduce pain, which is why it is preferred for periorbital and full-face protocols. Honest framing: published Rejuran trials report transient injection-site pain in 90%+ of patients, with mild and short-lived swelling and erythema.

References5

The clinical claims on this page — device specs, efficacy timelines, safety profile — are supported by the primary sources below. Each citation links to the original paper or regulatory record.

  1. [1]Polynucleotides in Esthetic Medicine: A Systematic Review. J Cosmet Dermatol (Lampridou et al.) — systematic review, 9 studies, N=219 (2024).
  2. [2]Randomized Split-Face: Polycaprolactone vs Polynucleotide for Crow's Feet. J Cosmet Dermatol (Jeong et al.) — split-face RCT N=30, 12-week comparable efficacy (2019).
  3. [3]Highly Purified Polynucleotide vs Placebo for Atrophic Acne Scars. Aesthet Surg J (Araco & Araco) — double-blind RCT N=20 (2021).
  4. [4]Expert Perspectives on Polynucleotides in Aesthetic Medicine. Clin Cosmet Investig Dermatol (Rho et al.) — expert panel review (PharmaResearch co-authors) (2026).
  5. [5]Polydeoxyribonucleotide as a Wound-Healing Platform. Pharmaceuticals (Galeano et al.) — 25-year pharmacology review (2021).

Notice

  • Active skin infection or inflammation at injection site
  • Known hypersensitivity to polynucleotide or salmon-derived products
  • Active autoimmune connective tissue disease (relative — requires dermatologist review)
  • Active bleeding diathesis or recent anticoagulant use without physician clearance
  • Pregnancy or lactation (no efficacy/safety data — elective procedure deferred)
  • Recent (within 4 weeks) injection of permanent filler in the same area (relative)
  • Keloid-prone patients in atrophic-scar protocols (relative)
Session summary & comparison
Rejuran — session summary
ItemDetails
Treatment timeabout 20-30 minutes
Pain & comfortIntradermal micro-injections are genuinely uncomfortable; topical anaesthetic is standard, and the HB Plus formulation contains lidocaine to reduce pain
DowntimeMinimal — mild bumps and minor bruising settle within 24-48 hours
Course & onsetStandard induction is 3 sessions 2-4 weeks apart; texture change is usually visible between the second and third session, fullest about 1 month after the course
MaintenanceRoughly every 3-6 months, based on how your skin responds
Reviewed byDr. SangYoul Yun· Board-Certified Dermatologist · AAD International Fellow (IFAAD)· Last reviewed 2026-05-14

Related procedures

Evidence & comparison guides

Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.

Next Step

Not sure this is the right route for you?

Message your concern for an honest read from a board-certified dermatologist. Free consultation — no pressure.

Gangnam, Seoul

Personalized dermatology care in Gangnam for local and overseas patients.

Delight Dermatology Clinic focuses on doctor-led consultation, warm service, and personalized treatment planning.

Clinic

Delight Dermatology Clinic

4th Floor, Building B, 509 Gangnam-daero

Seocho-gu, Seoul, South Korea

Parking is available in the building.

02-517-9991

Mon - Fri: 10:00 - 20:00

Lunch break: 13:00 - 14:00

Saturday: 10:00 - 16:00

Sunday and public holidays: Closed

Location

Gangnam · Seocho-gu, Seoul

Find directions

Clinic Name: 딜라이트피부과의원Representative: 윤상열Tel. 02-517-9991Business Registration No.: 357-15-02460Privacy PolicyTerms of Use
Registered Foreign Patient Medical Institution
Officially registered by the Ministry of Health and Welfare of the Republic of Korea (Reg. No. M-2024-01-08-8248) · 외국인환자 유치의료기관

Medical information on this site is for reference only and does not constitute medical advice. Individual results may vary. Consult a board-certified dermatologist for diagnosis and treatment planning.